Compliance With Antibiotic Treatment in General Practice
NCT ID: NCT01291251
Last Updated: 2012-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
270 participants
OBSERVATIONAL
2010-02-28
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improved Use of Antibiotic Guidelines in Hospital Environment
NCT00512772
Respiratory Tract Infections and Prescription Drugs in Children and in Pregnancy
NCT01109589
Antibiotic Therapy in Viral Airway Infections
NCT05045612
The Norwegian Antibiotics for Pneumonia in Children Study
NCT03446534
An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice
NCT00272155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Tablets administrated by public health care services
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Medical Association
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Torunn Bjerve Eide
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mette Brekke, Ph D
Role: STUDY_DIRECTOR
University of Oslo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hisøy legekontor
Arendal, Aust-Agder, Norway
Froland legekontor
Frøland, Aust-Agder, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VH-TBE-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.